News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,492 Results
Type
Article (88759)
Company Profile (816)
Press Release (793895)
Multimedia
Podcasts (236)
Webinars (35)
Section
Business (233581)
Career Advice (4162)
Deals (39984)
Drug Delivery (177)
Drug Development (91697)
Employer Resources (207)
FDA (18552)
Job Trends (17484)
News (398712)
Policy (40013)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (56)
ADA (48)
Adcomms (40)
Allergies (194)
Alliances (56989)
ALS (235)
Alzheimer's disease (1963)
Antibody-drug conjugate (ADC) (551)
Approvals (18885)
Artificial intelligence (863)
ASCO (345)
Autoimmune disease (354)
Automation (63)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (84)
Breast cancer (835)
Cancer (6539)
Cardiovascular disease (552)
Career advice (3597)
Career pathing (52)
CAR-T (381)
CDC (76)
Celiac Disease (3)
Cell therapy (1061)
Cervical cancer (54)
Clinical research (78945)
Collaboration (2348)
Company closure (8)
Compensation (1503)
Complete response letters (105)
COVID-19 (3039)
CRISPR (124)
C-suite (1271)
Cystic fibrosis (167)
Data (8637)
Decentralized trials (3)
Denatured (90)
Depression (192)
Dermatology (96)
Diabetes (699)
Diagnostics (7585)
Digital health (68)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (420)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (315)
Earnings (102478)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138591)
Executive appointments (1189)
FDA (22593)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1921)
Gene editing (270)
Generative AI (89)
Gene therapy (846)
GLP-1 (1284)
Government (5558)
Grass and pollen (8)
Guidances (419)
Healthcare (21252)
Hematology (198)
HIV (93)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (352)
Immuno-oncology (114)
Indications (203)
Infectious disease (3434)
Inflammatory bowel disease (241)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (317)
Interviews (821)
IPO (17998)
IRA (61)
Job creations (5208)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (120)
Layoffs (685)
Leadership (53)
Legal (10171)
Liver cancer (110)
Longevity (36)
Lung cancer (869)
Lymphoma (463)
Machine learning (66)
Management (66)
Manufacturing (1210)
MASH (225)
Medical device (15268)
Medtech (15419)
Mergers & acquisitions (23273)
Metabolic disorders (1814)
mRNA (264)
Multiple sclerosis (204)
NASH (24)
Neurodegenerative disease (503)
Neuropsychiatric disorders (126)
Neuroscience (3698)
Neurotech (2)
NextGen: Class of 2026 (7715)
Non-profit (5142)
Now hiring (80)
Obesity (867)
Opinion (373)
Ovarian cancer (242)
Pain (283)
Pancreatic cancer (347)
Parkinson's disease (414)
Partnered (39)
Patents (649)
Patient recruitment (745)
Peanut (70)
People (67960)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24400)
Phase 2 (34288)
Phase 3 (25788)
Pipeline (9651)
Policy (396)
Postmarket research (3559)
Preclinical (10975)
Press Release (72)
Prostate cancer (345)
Psychedelics (68)
Radiopharmaceuticals (371)
Rare diseases (1256)
Real estate (7462)
Recruiting (81)
Regulatory (30345)
Reports (77)
Research institute (2769)
Resumes & cover letters (654)
Rett syndrome (42)
RNA editing (29)
RSV (98)
Schizophrenia (195)
Series A (324)
Series B (234)
Service/supplier (28)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4370)
State (2)
Stomach cancer (21)
Supply chain (145)
Tariffs (104)
The Weekly (143)
Vaccines (1303)
Venture capital (131)
Weight loss (595)
Women's health (139)
Worklife (24)
Date
Today (130)
Last 7 days (684)
Last 30 days (3315)
Last 365 days (33202)
2026 (15854)
2025 (33219)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (397)
Arkansas (16)
Asia (52265)
Australia (9189)
California (14319)
Canada (3994)
China (1557)
Colorado (613)
Connecticut (637)
Delaware (441)
Europe (120533)
Florida (2120)
Georgia (465)
Hawaii (4)
Idaho (70)
Illinois (1239)
India (102)
Indiana (662)
Iowa (25)
Japan (585)
Kansas (143)
Kentucky (56)
Louisiana (64)
Maine (89)
Maryland (1736)
Massachusetts (10461)
Michigan (421)
Minnesota (796)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3794)
New Mexico (35)
New York (3758)
North Carolina (1927)
North Dakota (11)
Northern California (7112)
Ohio (444)
Oklahoma (26)
Oregon (55)
Pennsylvania (2826)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5620)
Tennessee (226)
Texas (2328)
United States (51192)
Utah (426)
Vermont (1)
Virginia (363)
Washington D.C. (89)
Washington State (1177)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 883,492 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bavarian Nordic Secures Additional Government Contract for the Supply of Smallpox/Mpox Vaccine
June 9, 2026
·
3 min read
Press Releases
Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research
June 9, 2026
·
4 min read
Press Releases
PainTEQ Announces First Patient Enrolled in the TRAQTION Study
June 9, 2026
·
3 min read
Press Releases
TREOS Bio Presents New PEPI Technology Data at EACR 2026, Including Six-Year Cancer-Free Outcome in MSS Metastatic Colorectal Cancer (mCRC)
June 9, 2026
·
5 min read
Press Releases
Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies
June 9, 2026
·
4 min read
Press Releases
BioPorto initiates U.S. Adult Validation Study following U.S. Food and Drug Administration (FDA) feedback
June 9, 2026
·
5 min read
Weight loss
ADA: AstraZeneca hands Structure a win with ‘relatively underwhelming’ GLP-1 pill data
AstraZeneca is pushing its small molecule GLP-1 drug to Phase 3 development for weight control, diabetes and other cardiometabolic conditions despite the asset failing to best one from Structure Therapeutics.
June 9, 2026
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
GSK pays $10.6B for cancer biotech Nuvalent in industry’s second-biggest buy of the year
Nuvalent Bio is GSK’s third big-ticket purchase this year, after the pharma dropped $2.2 billion in January for RAPT Therapeutics and $950 million in February for 35Pharma.
June 9, 2026
·
2 min read
·
Tristan Manalac
Diabetes
ADA: Lilly bests Novo again, takes GLP-1 pill Foundayo to FDA for diabetes approval
Newly approved weight loss pill Foundayo reduced blood sugar more than Novo Nordisk’s semaglutide and other comparators in multiple Phase 3 type 2 diabetes trials. Eli Lilly will seek approval in this indication.
June 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity
June 9, 2026
·
4 min read
1 of 88,350
Next
